Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $58.73 USD
Change Today +1.02 / 1.77%
Volume 120.5K
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

balchem corp (BCPC) Snapshot

Open
$58.26
Previous Close
$57.71
Day High
$58.77
Day Low
$57.37
52 Week High
12/23/14 - $69.92
52 Week Low
01/22/15 - $50.81
Market Cap
1.8B
Average Volume 10 Days
150.8K
EPS TTM
$2.00
Shares Outstanding
31.5M
EX-Date
12/24/14
P/E TM
29.4x
Dividend
$0.30
Dividend Yield
0.51%
Current Stock Chart for BALCHEM CORP (BCPC)

Related News

No related news articles were found.

balchem corp (BCPC) Related Businessweek News

No Related Businessweek News Found

balchem corp (BCPC) Details

Balchem Corp. develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries, primarily in the U.S. Its encapsulated/nutritional products segment provides solutions to various applications in food, pharmaceutical, and nutritional ingredients. It also offers human-grade choline nutrient products for wellness applications and calcium carbonate products, as well as products for the animal health industry. Its specialty products segment is a leader in packaging and distributing hazardous chemicals and is the leading supplier of packaged 100% ethylene oxide to the health-care industry, where it is used as a sterilant for medical items. The Ingredients segment manufactures and supplies choline chloride, a nutrient for animal health, to the poultry and swine industries. It also manufactures derivatives of choline chloride. Balchem was founded in 1967 and is headquartered in New Hampton, N.Y.

845 Employees
Last Reported Date: 02/27/15
Founded in 1967

balchem corp (BCPC) Top Compensated Officers

Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $220.0K
General Counsel and Secretary
Total Annual Compensation: $212.0K
Vice President of Administration and Assistan...
Total Annual Compensation: $266.0K
Vice President and General Manager of Special...
Total Annual Compensation: $253.0K
Compensation as of Fiscal Year 2014.

balchem corp (BCPC) Key Developments

Balchem Corporation Appoints Dino A. Rossi as Non-Executive Chairman

Balchem Corporation announced that, effective September 1, 2015, former President and Chief Executive Officer and current Executive Chairman, Dino A. Rossi, will transition into service solely as the non-executive Chairman of the Board of Directors of the company. The company appointed Theodore Harris as its new President and Chief Executive Officer effective April 28, 2015, at which time Mr. Rossi was appointed Executive Chairman to help guide the company through the transition period.

Balchem Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Balchem Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $134.773 million compared to $132.230 million a year ago. Earnings from operations were of $23.774 million compared to $16.509 million a year ago. Earnings before income tax expense was $22.167 million compared to $15.291 million a year ago. Net earnings were $14.916 million or $0.47 per diluted share compared to $9.732 million or $0.31 per diluted share a year ago. Non-GAAP earnings from operations were of $30.393 million compared to $27.396 million a year ago. Non-GAAP net earnings were of $19.476 million or $0.62 per diluted share compared to $16.661 million or $0.53 per diluted share a year ago. Adjusted EBITDA was $34.998 million compared to $30.918 million a year ago. EBITDA was $33.486 million compared with $23.639 million a year ago. The company reported $8.9 million of capital expenditure funding in the quarter. For six months, the company reported net sales of $279.635 million compared to $218.225 million a year ago. Earnings from operations were of $48.812 million compared to $29.864 million a year ago. Earnings before income tax expense was $45.252 million compared to $28.663 million a year ago. Net earnings were $30.088 million or $0.95 per diluted share compared to $18.626 million or $0.60 per diluted share a year ago. Net cash provided by operating activities was $49.866 million compared to $27.603 million a year ago. Capital expenditures and intangible assets acquired were of $15.916 million compared to $3.545 million a year ago. Non-GAAP earnings from operations were of $62.045 million compared to $43.091 million a year ago. Non-GAAP net earnings were of $39.095 million or $1.24 per diluted share compared to $27.221 million or $0.87 per diluted share a year ago. Adjusted EBITDA was $71.079 million compared to $49.237 million a year ago. EBITDA was $68.393 million compared with $39.625 million a year ago.

Balchem Eyes Acquisitions

Balchem Corp. (NasdaqGS:BCPC) is seeking acquisitions. Ted Harris, President and Chief Executive Officer of Balchem noted, as one of the action plans, to aggressively explore possible alliance, acquisition, and/or joint venture opportunities, to build and leverage on our strategic platforms, technologies, and strong human asset base. We have a good pipeline of opportunities that we are working actively.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCPC:US $58.73 USD +1.02

BCPC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $21.75 USD +0.05
Corbion NV €19.26 EUR +0.205
Ion Beam Applications €27.76 EUR +0.195
Wessanen €9.48 EUR +0.195
Terra Nitrogen Co LP $111.37 USD +0.13
View Industry Companies
 

Industry Analysis

BCPC

Industry Average

Valuation BCPC Industry Range
Price/Earnings 28.2x
Price/Sales 3.0x
Price/Book 4.1x
Price/Cash Flow 28.2x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BALCHEM CORP, please visit www.balchem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.